Stereotactic Body Radiation Therapy: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Stereotactic Body Radiation Therapy

• A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
  NCT07619599 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)
  NCT04985032 · Phase: Not specified · Ages: 50 Years to 100 Years · Sex: Female · 2 locations
• Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
  NCT05915442 · Phase: Phase 2 · Ages: 18 Years to 99 Years · Sex: Male · 1 location
• Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
  NCT06014827 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
  NCT07548164 · Phase: Phase 3 · Ages: No age limits stated · Sex: Male · 8 locations
• Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
  NCT03422302 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
  NCT04693377 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
  NCT05616650 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: Male · 1 location
• High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
  NCT04945642 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
  NCT06130826 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.
  NCT06369246 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
  NCT05830058 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
  NCT04959474 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
  NCT06623656 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
  NCT06141031 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
  NCT06794086 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
  NCT06205316 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 6 locations
• SBRT in Early Breast Cancer in Elderly Women
  NCT05071105 · Phase: Not applicable (e.g. observational or device study) · Ages: 75 Years and older · Sex: Female · 1 location
• Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
  NCT05802186 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
  NCT06378866 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations
• Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
  NCT06260033 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors
  NCT03392233 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
  NCT05946213 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 413 locations
• Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
  NCT05624996 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 477 locations
• Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
  NCT03492671 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
  NCT06738160 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation
  NCT06843551 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
  NCT04423211 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 341 locations
• Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
  NCT06276465 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 4 locations

Common questions

How many recruiting trials involve Stereotactic Body Radiation Therapy?

29 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.